Clinical Trials Directory

Trials / Completed

CompletedNCT05093023

ABCB1 SNPs as Predictors of PIPN

ABCB1 Single Nucleotide Polymorphism Genotypes as Predictors of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
92 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study aim is to determine the allele frequencies of 1236 G\>A and 3435 G\>A in ABCB1 and study their association with the incidence and severity of paclitaxel-induced peripheral neuropathy while adjusting for other baseline covariates in Egyptian patients. Additionally, the study aimed at fitting and validating logistic regression models with the aforementioned SNPs evaluated in additive, dominant, overdominant, and recessive genetic models and performing diagnostics for the best model in terms of internal validity.

Conditions

Interventions

TypeNameDescription
GENETICReal-Time PCRGenomic DNA was extracted from 2 ml of venous blood. ABCB1 1236 G\>A and 3435 G\>A were genotyped using predesigned TaqMan SNP genotyping assays on a stepOne PCR instrument in accordance with the manufacturer's protocol.

Timeline

Start date
2018-03-01
Primary completion
2020-01-01
Completion
2020-01-31
First posted
2021-10-26
Last updated
2021-10-26

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05093023. Inclusion in this directory is not an endorsement.